91 related articles for article (PubMed ID: 27802165)
21. Massively Parallel Functional Analysis of BRCA1 RING Domain Variants.
Starita LM; Young DL; Islam M; Kitzman JO; Gullingsrud J; Hause RJ; Fowler DM; Parvin JD; Shendure J; Fields S
Genetics; 2015 Jun; 200(2):413-22. PubMed ID: 25823446
[TBL] [Abstract][Full Text] [Related]
22. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
[TBL] [Abstract][Full Text] [Related]
23. The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2.
Guaragnella N; Palermo V; Galli A; Moro L; Mazzoni C; Giannattasio S
FEMS Yeast Res; 2014 Feb; 14(1):2-16. PubMed ID: 24103154
[TBL] [Abstract][Full Text] [Related]
24. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
25. Casein kinase 2 binds to and phosphorylates BRCA1.
O'Brien KA; Lemke SJ; Cocke KS; Rao RN; Beckmann RP
Biochem Biophys Res Commun; 1999 Jul; 260(3):658-64. PubMed ID: 10403822
[TBL] [Abstract][Full Text] [Related]
26. Mislocalization of BRCA1-complex due to ABRAXAS Arg361Gln mutation.
Vikrant ; Kumar R; Siddiqui Q; Singh N; Waghmare SK; Varma AK
J Biomol Struct Dyn; 2015; 33(6):1291-301. PubMed ID: 25105795
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
[TBL] [Abstract][Full Text] [Related]
28. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
Hayes F; Cayanan C; Barillà D; Monteiro AN
Cancer Res; 2000 May; 60(9):2411-8. PubMed ID: 10811118
[TBL] [Abstract][Full Text] [Related]
29. Variant of uncertain significance Arg866Cys enhances disorderedness of h-BRCA1 (759-1064) region.
Mishra N; Dubey S; Kumari A; Siddiqui MQ; Kuligina E; Varma AK
Int J Biochem Cell Biol; 2024 Mar; 168():106527. PubMed ID: 38242199
[TBL] [Abstract][Full Text] [Related]
30. Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion.
Abdelmoula-Souissi S; Delahodde A; Bolotin-Fukuhara M; Gargouri A; Mokdad-Gargouri R
Apoptosis; 2011 Jul; 16(7):746-56. PubMed ID: 21553245
[TBL] [Abstract][Full Text] [Related]
31. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
32. Positional analyses of BRCA1-dependent expression in Saccharomyces cerevisiae.
Skibbens RV; Ringhoff DN; Marzillier J; Cassimeris L; Eastman L
Cell Cycle; 2008 Dec; 7(24):3928-34. PubMed ID: 19098428
[TBL] [Abstract][Full Text] [Related]
33. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
34. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
Carvalho M; Pino MA; Karchin R; Beddor J; Godinho-Netto M; Mesquita RD; Rodarte RS; Vaz DC; Monteiro VA; Manoukian S; Colombo M; Ripamonti CB; Rosenquist R; Suthers G; Borg A; Radice P; Grist SA; Monteiro AN; Billack B
Mutat Res; 2009 Jan; 660(1-2):1-11. PubMed ID: 18992264
[TBL] [Abstract][Full Text] [Related]
35. Yeast as a model to study protein misfolding in aged cells.
Di Gregorio SE; Duennwald ML
FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29905793
[TBL] [Abstract][Full Text] [Related]
36. In vitro analysis of genomic instability triggered by BRCA1 missense mutations.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Cuda G; Costanzo F; Venuta S
Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786532
[TBL] [Abstract][Full Text] [Related]
37. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.
Huber LJ; Yang TW; Sarkisian CJ; Master SR; Deng CX; Chodosh LA
Mol Cell Biol; 2001 Jun; 21(12):4005-15. PubMed ID: 11359908
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 16 years later: nuclear import and export processes.
Thompson ME
FEBS J; 2010 Aug; 277(15):3072-8. PubMed ID: 20608972
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
40. Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.
Li H; Sekine M; Tung N; Avraham HK
Mol Cancer Res; 2010 Mar; 8(3):407-20. PubMed ID: 20215423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
